AzTrials
AzTrials

FrailtyFRAILPOLNCT04518423

Prevalence, Determinants and Natural History of Frailty and Pre-frailty in Elderly People

An observational study of Frailty and Frailty Syndrome, run by The Opole University of Technology at 1 site in Poland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Frailty syndrome (i.e. frailty) is a geriatric syndrome which relies on the reduction of multisystem reserve capacity. Frail people have a lower potential to respond to external stressors and various life incidents as well as they present a weak prognosis particularly in cardiovascular diseases. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Frailty, Frailty Syndrome, Frail Elderly Syndrome
How many people
1,093 participants
Where
1 sitePoland
Study dates
2 Sep 2017to Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Study population: The study group will comprise community dwelling elderly individuals over the age of 65 years who get around by themselves.

Who may be able to join

  • Community dwelling elderly individuals over the age of 65 years who get around by themselves.

Who cannot join

  • Institutionalization
  • Inability to move around
  • Terminal diseases with an anticipated survival of less than 1 year.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jerzy Sacha, MD, PhD contact

+48 600 273 616

j.sacha@po.edu.pl

Zbigniew Borysiuk, PhD contact

+48 77 449 82 50

z.borysiuk@po.edu.pl

Poland1 site, 1 recruiting
  • Faculty of Physical Education and Physiotherapy, Opole University of Technology

    Opole, 45-758

    Jerzy Sacha, MD, PhD, +48 600 273 616, j.sacha@po.edu.pl

    Zbigniew Borysiuk, PhD, +48 77 449 82 50, z.borysiuk@po.edu.pl

    Recruiting

Other trials in Poland

About this study

Official title: Prevalence, Determinants and Natural History of Frailty and Pre-frailty in People Over the Age of 65 Years in a Prospective 5-year Observation

Frailty syndrome (i.e. frailty) is a geriatric syndrome which relies on the reduction of multisystem reserve capacity. Frail people have a lower potential to respond to external stressors and various life incidents as well as they present a weak prognosis particularly in cardiovascular diseases. Yet, frailty is not only a set of physical deficits, but it also concerns psychological and social dimensions of human functioning. Hence, an approach to frailty should be multidimensional because such a concept more adequately reflects a functional degradation in the elderly. Frailty is usually associated with the impaired condition of circulatory system, and therefore, an identification of subclinical cardiovascular abnormalities is paramount in the frailty prevention and treatment. Another potential mechanism which may predispose to frailty is a dysfunction of the autonomic nervous system. This system plays a crucial role in the response to internal or external stressors such as diseases and activities of daily living. An impairment of the autonomic nervous system function may maintain or accelerate the frailty process.

In this scientific project, a comprehensive echocardiography will investigate cardiac function with a particular attention to features which typically change with age, like flow parameters and chambers sizes. The activity of the autonomic nervous system will be explored with the analysis of heart rate, blood pressure and respiratory signals. The study participants will also undergo routine medical examination and a number of additional tests, including: assessment of cognitive function, psychological condition, nutrition status, activities of daily living, and risk of falls. The study group will comprise community dwelling elderly individuals over the age of 65 years who get around by themselves. After 2 years, the participants will be re-examined for their frailty and independence status, as well as their survival will be checked with the National Health Found electronic system. The aim of this project is to seek for factors determining frailty and to explore the frailty impact on the elderly people survival. Particular attention will be paid to the multidimensional frailty which is a new concept of the functional decline in the elderly. In addition, the prevalence of different modes of frailty in Polish community will be investigated. The results of this research should help to establish preventative and therapeutic strategies against frailty.

Read the detailed description

Frailty is a geriatric syndrome which relies on the reduction of multisystem reserve capacity, whereas pre-frailty is a condition predisposing and preceding the frailty state. Frail people have a lower potential to respond to external stressors and various life incidents as well as they present a weak prognosis particularly in cardiovascular diseases. However, frailty is not only a set of physical deficits, but it also concerns psychological and social dimensions of human functioning. Hence, an approach to frailty should be multidimensional because such a concept more adequately reflects a functional degradation in the elderly. Frailty is usually associated with the impaired condition of circulatory system, and therefore, an identification of subclinical cardiovascular abnormalities which are associated with frailty is paramount in a context of frailty prevention and treatment. In this study, a comprehensive echocardiography will investigate cardiac function with a particular attention to features which typically change with age, like flow and diastolic parameters, as well as chambers sizes. Specifically, the impact of the impaired diastolic filling pattern on the frailty development will be thoroughly investigated. Another potential mechanism which may predispose to frailty is a dysfunction of the autonomic nervous system (ANS) - especially, its cardiac branch. ANS plays a crucial role in the response to internal or external stressors such as diseases and activities of daily living, and it plays a pivotal role in the homeostasis. Since frail people present a progressive homeostatic dysregulation, it is possible that the impairment in the cardiac ANS may maintain or accelerate the frailty process. In the present study, both tonic and reflex activities of the cardiac ANS will be explored with Finapres device (Finapres Medical Systems B.V., Amsterdam, the Netherlands) which is a gold standard for non-invasive continuous blood pressure monitoring and also allows ECG and respiratory signals recording. The study participants will also undergo routine medical examination, standard 12-lead electrocardiography, and measurements of body mass index and ankle-brachial index - the latter will reflect the degree of lower extremity arterial disease. A cognitive function and a psychological condition will be evaluated with the Mini-Mental State Examination (MMSE) and the Geriatric Depression Scale, respectively. A nutrition status will be checked with the Mini Nutritional Assessment (MNA). The Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) will be assessed with dedicated scales. A risk of fall will be judged with the questionnaire concerning the falls history and by examining a postural stability on a force plate (AccuSway, AMTI, Watertown, MA, USA). The study group will comprise community dwelling elderly individuals over the age of 65 years who get around by themselves. The exclusion criteria include: institutionalization, inability to move around, and terminal diseases with an anticipated survival of less than 1 year. After 2 and 5 years, the participants will be re-examined for their frailty and independence status, and in addition, their life status will be checked with national identification numbers by using the National Health Found registration system. Sample size calculation indicates that the minimum sample size to investigate frailty development should equal 994 subjects (1% margin of error and 95% confidence interval), however, assuming 10% loss in follow-up, the final sample size is 1093 subjects.

The primary endpoints of this study are: (i) to identify risk factors associated with multidimensional and physical frailty and pre-frailty in community dwelling elderly people over the age of 65 years; (ii) to find determinants for the development of different types of frailty in a prospective observation. The secondary endpoints are: (i) to explore the impact of various modes of frailty and other clinical factors on the elderly people mortality; (ii) to identify predictors for frailty development, disability or mortality as a composite endpoint; (iii) to explore the rate and determinants of a frailty status transition to a more robust status; (iv) to establish the prevalence of multidimensional frailty, and physical frailty and pre-frailty in elderly people in Polish community; (v) to determine a concordance/discordance between physical and multidimensional frailty.

Keywords
Frailty, Physical Frailty, Cognitive Frailty, Social Frailty, Multidimensional Frailty, Elderly, Aging, Frail Scale, Tilburg Frailty Indicator
Medical subject headings
Frailty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT04518423
Study groupRoleWhat they receive
Elderly people over the age of 65 yearsThe study group will comprise community dwelling elderly individuals over the age of 65 years who get around by themselves. The subjects will be followed up for 5 years to investigate the frailty and disability development, and survival.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Risk factors associated with multidimensional and physical frailty and pre-frailty in community dwelling elderly people over the age of 65 years.

    Risk factors associated with the existing frailty at the study entry will be identified.

    Measured: At the study entry during the first examination.

  2. Determinants for the development of different types of frailty in a prospective observation

    Determinants of frailty developing during the study period will be identified.

    Measured: Through the study completion, an average of 5 years.

Secondary outcomes (5)
  1. The impact of various modes of frailty and other clinical factors on the elderly people mortality.

    Frailty impact on mortality in elderly people will be investigated.

    Measured: Through the study completion, an average of 5 years.

  2. Predictors for frailty development, disability or mortality as a composite endpoint.

    Determinants of frailty development, disability or mortality as a composite endpoint will be investigated.

    Measured: Through the study completion, an average of 5 years.

  3. The rate and determinants of a frailty status transition to a more robust status.

    The rate and determinants of the recovery from different statuses of frailty will be investigated.

    Measured: Through the study completion, an average of 5 years.

  4. The prevalence of multidimensional frailty, and physical frailty and pre-frailty in elderly people in Polish community.

    The prevalence of different types of frailty in Polish community will be investigated.

    Measured: Through the study completion, an average of 5 years.

  5. The concordance and discordance between physical and multidimensional frailty.

    The concordance and discordance between different types of frailty will be investigated.

    Measured: Through the study completion, an average of 5 years.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Aug 2020
  2. Study start2 Sep 2017
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,093 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04518423
Sponsor's protocol ID
FRAILPOL
Acronym
FRAILPOL
Status last verified
Aug 2020
First submitted
12 Aug 2020
Last updated
19 Aug 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Potentially some data will be shared for research purposes and after investigators agreement.

Questions about this trial

What is this clinical trial studying?

An observational study of Frailty and Frailty Syndrome, run by The Opole University of Technology at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jerzy Sacha, MD, PhD (+48 600 273 616, j.sacha@po.edu.pl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Risk factors associated with multidimensional and physical frailty and pre-frailty in community dwelling elderly people over the age of 65 years. (time frame: At the study entry during the first examination.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in